Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University School of Medicine and Siteman Cancer Center, 4911 Barnes Jewish Hospital Plaza, St. Louis, MO 63110, USA.
Gynecol Oncol. 2010 Mar;116(3):370-3. doi: 10.1016/j.ygyno.2009.11.031. Epub 2009 Dec 16.
A 10-point "Surgical Apgar Score" (SAS) for predicting postoperative complications after general and vascular operations has recently been developed and validated. We sought to estimate the ability of this metric to predict major postoperative complications in women undergoing ovarian cancer cytoreductive procedures.
All eligible patients with stage III and IV epithelial ovarian, fallopian tube and primary peritoneal cancer undergoing surgical cytoreduction at our institution between 1999 and 2005 were included. Medical records were reviewed and demographic data, clinicopathologic characteristics, comorbidities and intra and postoperative complications were analyzed. The surgical score was calculated from intraoperative blood loss, lowest mean arterial pressure and lowest heart rate as previously described. Descriptive statistics, univariable and multivariable analyses were used as appropriate. Occurrence of major postoperative complications represented the primary outcome.
A total of 232 cases were analyzed. Mean age was 62 years. Most patients were Caucasian (92%) and diagnosed with stage III disease (83%). Mean duration of surgical procedure was 171 (70-350) minutes. Median SAS was 6 points (range 1-9). On multivariable analyses, occurrence of major postoperative complications was associated with multiple comorbidities (OR 2.2; 95% CI:1.5-3.1; p<0.0001), stage IV disease (OR 2.5; 95% CI:1.1-5.7; p=0.03), ASA class (OR 2.4; 95% CI:1.2-4.7; p=0.01) and SAS<or=4 (OR 7.4; 95% CI:2.9-18.8; p<0.0001).
Lower SAS (<or=4) is the most powerful predictor of postoperative complications in patients undergoing cytoreductive surgery for advanced epithelial ovarian cancer. This prognostic tool may prove helpful for triaging such patients to optimal postoperative levels of care and directing counseling, monitoring and management in the postoperative period.
最近开发并验证了一种用于预测普通和血管手术后并发症的 10 分“手术 Apgar 评分”(SAS)。我们旨在评估该指标预测接受卵巢癌细胞减灭术的女性患者发生主要术后并发症的能力。
本研究纳入了 1999 年至 2005 年期间在我院接受手术细胞减灭术的 III 期和 IV 期上皮性卵巢癌、输卵管癌和原发性腹膜癌患者。回顾了病历,并分析了人口统计学数据、临床病理特征、合并症和围手术期并发症。手术评分是根据术中失血量、最低平均动脉压和最低心率按先前描述的方法计算的。使用适当的描述性统计、单变量和多变量分析。主要术后并发症的发生为主要结局。
共分析了 232 例病例。平均年龄为 62 岁。大多数患者为白人(92%),诊断为 III 期疾病(83%)。手术时间平均为 171 分钟(70-350 分钟)。中位 SAS 为 6 分(范围 1-9 分)。多变量分析显示,主要术后并发症的发生与多种合并症(OR 2.2;95%CI:1.5-3.1;p<0.0001)、IV 期疾病(OR 2.5;95%CI:1.1-5.7;p=0.03)、ASA 分级(OR 2.4;95%CI:1.2-4.7;p=0.01)和 SAS<or=4(OR 7.4;95%CI:2.9-18.8;p<0.0001)有关。
SAS 值较低(<or=4)是预测接受高级上皮性卵巢癌细胞减灭术患者术后并发症的最有力指标。这种预测工具可能有助于对这些患者进行分诊,以获得最佳的术后护理水平,并在术后期间提供咨询、监测和管理。